NuCana (NCNA) Amortization (2016 - 2025)
NuCana's (NCNA) quarterly Amortization came in at -$2.5 million in Q4 2025, down 44.07% year-on-year from -$4.4 million in Q4 2024, and down 106.14% quarter-over-quarter from $40.3 million in Q3 2025.
NuCana (NCNA) Amortization (2016 - 2025) Analysis & Trends
NuCana has disclosed Amortization across 10 years of filings, most recently posting -$2.5 million for Q4 2025.
- Amortization for Q4 2025 came in at -$2.5 million, down 44.07% year-over-year; the trailing twelve-month figure through Dec 2025 was -$19.6 million (up 24.63% YoY), and the FY2025 annual result was $35.4 million, up 125.9% from the prior year.
- Amortization came in at -$2.5 million for Q4 2025 at NuCana, down from $40.3 million in the prior quarter.
- In the past five years, Amortization ranged from a high of $120.8 million in Q2 2021 to a low of -$13.7 million in Q3 2023.
- The 5-year median for Amortization is $4.9 million (2024), against an average of $27.6 million.
- Across the five-year window, Amortization sank 118.67% in 2023 and jumped 795.88% in 2025, its largest moves.
- NuCana's Amortization stood at $96.5 million in 2021, then sank by 33.27% to $64.4 million in 2022, then sank by 113.79% to -$8.9 million in 2023, then jumped by 80.67% to -$1.7 million in 2024, then tumbled by 44.07% to -$2.5 million in 2025.
- The last three Amortization figures came in at -$2.5 million (Q4 2025), $40.3 million (Q3 2025), and $18.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | -2.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.47 Mn |
| Dec 31, 2025 | -2.47 Mn |
| Sep 30, 2025 | 40.26 Mn |
| Sep 30, 2025 | 40.26 Mn |
| Jun 30, 2025 | 18.32 Mn |
| Jun 30, 2025 | 18.32 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | 21.89 Mn |
| Jun 30, 2024 | 21.89 Mn |
| Mar 31, 2024 | -9.64 Mn |
| Mar 31, 2024 | -9.64 Mn |
| Dec 31, 2023 | -8.88 Mn |
| Dec 31, 2023 | -8.88 Mn |
| Sep 30, 2023 | -13.74 Mn |
| Sep 30, 2023 | -13.74 Mn |